Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Janku Filip sold 5,407 Monte Rosa Therapeutics, Inc. shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 1, 2026
On Jun 30, 2026, Janku Filip (Chief Medical Officer) sold 5,407 Monte Rosa Therapeutics, Inc. shares at US$24.50 for US$132K under a trading plan, leaving 60,612 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 5,407 shares
- Price
- US$24.50
- Value
- US$132K
- Holding after
- 60,612 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Option exercise | 5,407 | US$13.41 | 66,019 | Direct |
| Jun 30, 2026 | Common Stock | Sale | 5,407 | US$24.50 | 60,612 | Direct |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Janku Filip
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Janku Filip · Jun 30, 2026
- Form 4 · Janku Filip · Jun 25, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026